Screener
Viridian Therapeutics, Inc. VRDN Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001590750-26-000018
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Interest expense | (8,307) | (514) | (11,769) | (1,100) |
| Change in fair value of derivative liability | (1,190) | — | 6,340 | — |
| Other income (expense), net | 156 | — | (516) | — |
| Total other income (expense), net | (851) | 6,032 | 10,417 | 12,986 |
| Net loss | $(127,119) | $(100,735) | $(232,020) | $(187,647) |
| Net loss per share, basic and diluted, common stock | $(1.05) | $(1.00) | $(1.95) | $(1.87) |
| Weighted-average common shares outstanding, basic and diluted | 107,884,104 | 81,593,463 | 105,063,550 | 81,471,496 |
| Net loss per share, basic and diluted, Series A convertible preferred stock | $(69.72) | $(66.99) | $(129.94) | $(124.93) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Viridian Therapeutics, Inc.'s other income (expense)?
- Viridian Therapeutics, Inc. (VRDN) reported other income (expense) of -$851K in Q2 2026.
- How has Viridian Therapeutics, Inc.'s other income (expense) changed year-over-year?
- Viridian Therapeutics, Inc.'s other income (expense) decreased by 114.1% year-over-year, from $6.03M to -$851K.
- What is the long-term trend for Viridian Therapeutics, Inc.'s other income (expense)?
- Over 4 years (2021 to 2025), Viridian Therapeutics, Inc.'s other income (expense) has grown at a 185.0% compound annual growth rate (CAGR), from $315K to $20.79M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Viridian Therapeutics, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude